This inventor holds 2 USPTO granted patents, plus 5 CIPO patents and 1 EPO patent. Top assignee: Adaerata, Limited Partnership. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Geneviève Dubuc: Innovator in Chimeric Proteins
Introduction
Geneviève Dubuc is a prominent inventor based in Longueuil, Canada. She has made significant contributions to the field of biochemistry, particularly in the development of chimeric proteins. With a total of 2 patents to her name, her work is paving the way for advancements in medical research and therapeutic applications.
Latest Patents
Geneviève's latest patents include innovative work on chimeric PCSK9 proteins. These patents describe a chimera protein that comprises a signal peptide, a proprotein convertase subtilisin/kexin type 9 preproprotein (PCSK9) sequence, a transmembrane domain, and a cytosolic domain. The cytosolic domain is designed to recycle the protein from the cellular membrane to endosomes, which is crucial for its functionality in cellular processes.
Career Highlights
Geneviève Dubuc is associated with Adaerata, Limited Partnership, where she continues to push the boundaries of scientific research. Her expertise in protein engineering and biochemistry has established her as a key figure in her field.
Collaborations
Throughout her career, Geneviève has collaborated with notable scientists, including Nabil G Seidah and Jean Davignon. These partnerships have enhanced her research and contributed to the success of her innovative projects.
Conclusion
Geneviève Dubuc's work in the field of chimeric proteins exemplifies her dedication to scientific innovation. Her contributions are not only advancing our understanding of biochemistry but also have the potential to lead to significant medical breakthroughs.